Cite
HARVARD Citation
Roblin, X. et al. (2017). Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease. Inflammatory bowel diseases. 23 (1), pp. 126-132. [Online].